Harmony Biosciences
HRMY
HRMY
231 hedge funds and large institutions have $2B invested in Harmony Biosciences in 2024 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 71 increasing their positions, 87 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 218 → 231 (+13)
0.16% less ownership
Funds ownership: 88.33% → 88.17% (-0.16%)
18% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 87
Holders
231
Holding in Top 10
6
Calls
$4.39M
Puts
$2M
Top Buyers
| 1 | +$13.3M | |
| 2 | +$12.7M | |
| 3 | +$11M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$7.76M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$21.2M | |
| 3 | -$16.8M | |
| 4 |
Millennium Management
New York
|
-$9.46M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$8.92M |